PT95625A - Processo para a preparacao de arilsulfatase - Google Patents

Processo para a preparacao de arilsulfatase

Info

Publication number
PT95625A
PT95625A PT95625A PT9562590A PT95625A PT 95625 A PT95625 A PT 95625A PT 95625 A PT95625 A PT 95625A PT 9562590 A PT9562590 A PT 9562590A PT 95625 A PT95625 A PT 95625A
Authority
PT
Portugal
Prior art keywords
arilsulfatase
preparation
conjuction
arylsulfatase
sulfated
Prior art date
Application number
PT95625A
Other languages
English (en)
Other versions
PT95625B (pt
Inventor
Toshikazu Oki
Koji Tomita
Yosuke Sawada
Tomokazu Ueki
Satoshi Yamamoto
Yasuo Fukagawa
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of PT95625A publication Critical patent/PT95625A/pt
Publication of PT95625B publication Critical patent/PT95625B/pt

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6899Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
  • Valve Device For Special Equipments (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT95625A 1989-10-20 1990-10-18 Processo para a preparacao de arilsulfatase PT95625B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42437689A 1989-10-20 1989-10-20

Publications (2)

Publication Number Publication Date
PT95625A true PT95625A (pt) 1991-09-13
PT95625B PT95625B (pt) 1997-08-29

Family

ID=23682406

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95625A PT95625B (pt) 1989-10-20 1990-10-18 Processo para a preparacao de arilsulfatase

Country Status (14)

Country Link
EP (1) EP0423818B1 (pt)
JP (1) JP3097035B2 (pt)
KR (1) KR0144351B1 (pt)
AT (1) ATE162217T1 (pt)
AU (1) AU638283B2 (pt)
CA (1) CA2027977C (pt)
DE (1) DE69031932T2 (pt)
DK (1) DK0423818T3 (pt)
ES (1) ES2111526T3 (pt)
FI (1) FI94362C (pt)
GR (1) GR3026042T3 (pt)
IE (1) IE903767A1 (pt)
PT (1) PT95625B (pt)
ZA (1) ZA908408B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0649330U (ja) * 1992-12-16 1994-07-05 オート化学工業株式会社 流動性物質の貯蔵用容器
GB9323429D0 (en) * 1993-11-12 1994-01-05 Wellcome Found Therapy
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
WO1997021818A1 (en) * 1995-12-14 1997-06-19 Kyoto Daiichi Kagaku Co., Ltd. Novel fructosyl amino acid oxidase originating in fungi of the genus penicillium
DE10155764A1 (de) * 2001-11-14 2003-05-28 Degussa Neue Sulfatasen und ihre Verwendung
JP4606712B2 (ja) 2003-01-08 2011-01-05 マサチューセッツ インスティテュート オブ テクノロジー 2−oスルファターゼ組成物および関連の方法
CA2674493C (en) 2007-01-05 2017-05-09 Massachusetts Institute Of Technology Compositions of and methods of using sulfatases from flavobacterium heparinum

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1262565A (fr) * 1956-05-16 1961-06-05 Procédé de fabrication de produits agricoles par fermentation et produits conformes à ceux ainsi obtenus
NZ225599A (en) * 1987-08-04 1991-09-25 Bristol Myers Co Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells

Also Published As

Publication number Publication date
FI94362C (fi) 1995-08-25
JP3097035B2 (ja) 2000-10-10
KR910008131A (ko) 1991-05-30
AU6470890A (en) 1991-04-26
DK0423818T3 (da) 1998-09-07
ZA908408B (en) 1992-06-24
JPH03155781A (ja) 1991-07-03
FI905107A0 (fi) 1990-10-17
EP0423818A1 (en) 1991-04-24
FI94362B (fi) 1995-05-15
PT95625B (pt) 1997-08-29
IE903767A1 (en) 1991-04-24
AU638283B2 (en) 1993-06-24
CA2027977C (en) 2000-01-18
ES2111526T3 (es) 1998-03-16
CA2027977A1 (en) 1992-04-19
EP0423818B1 (en) 1998-01-14
DE69031932D1 (de) 1998-02-19
ATE162217T1 (de) 1998-01-15
GR3026042T3 (en) 1998-04-30
DE69031932T2 (de) 1998-08-27
KR0144351B1 (ko) 1998-07-01

Similar Documents

Publication Publication Date Title
BRPI0012196B8 (pt) artigo industrializado
NZ334828A (en) Contains no O-acetyl groups detectable by NMR and binds to antibodies to S.aureus further conjugated with Pseudomonas aeruginosa exotoxin A as an immunocarrier to detect S.aureus infection
PT99067A (pt) Processo para a producao de um conjugado de oligossacarido e de uma proteina veiculo
BR9713521A (pt)
DE3687779D1 (de) Trichotecenkonjugate.
AU4393085A (en) Platinum co-ordination compounds
PT89923A (pt) Processo para a preparacao de variantes da hiridina
PT95625A (pt) Processo para a preparacao de arilsulfatase
IL95578A0 (en) Vaccine formed from a poly-saccharide and a protein
ES2131066T3 (es) Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
ES2092514T3 (es) Conjugados de anticuerpos de dominio variable.
DE69328779D1 (de) Benzodiazepin-derivate sowie deren konjugate mit proteinen und polypeptiden
YU46858B (sh) Postupak za dobijanje imunoglobulinskih konjugata
BR9813465A (pt) Polissacarìdeos modificados que exibem reconhecimento biológico alterado
DE69610948D1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
DK398086D0 (da) Fremgangsmaade til foroegelse af oploeseligheden af immunokonjugatpraeparationer eller ukonjugeret immunoglobulin samt fremgangsmaade til nedsaettelse af intakte toksinkonjugaters toksicitet
DE69006823D1 (de) Borquelle für Molekularstrahlepitaxie.
DE69912245D1 (de) Glykosidierung von 4,5-epoxymorphinan-6-olen
DE3888924D1 (de) Monoklonale Antikörper gegen Anthracycline.
ES2134873T3 (es) Composiciones farmaceuticas topicas que contienen anticuerpos monoclonales antiantraciclina.
PT774119E (pt) Moleculas de suporte oligomericas com grupos marcadores e haptenos incorporados de modo selectivo
DE69010307D1 (de) Fetthydrolyseverfahren.
NO951061L (no) Antistoffkonjugater med forbedrede egenskaper
CO4480037A1 (es) Vacunas que comprenden un antigeno polisacarido conjugado unido a una proteina portadora y adsorbido sobre fosfato de aluminio
FI940684L (fi) Menetelmä Streptococcus suis -bakteerin adhesiiniproteiinin ja sen vasta-aineen valmistamiseksi

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910401

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20111205

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120605